223 related articles for article (PubMed ID: 23058249)
1. Cytogenetic and molecular genetic study on granular cell glioblastoma: a case report.
Joo M; Park SH; Chang SH; Kim H; Choi CY; Lee CH; Lee BH; Hwang YJ
Hum Pathol; 2013 Feb; 44(2):282-8. PubMed ID: 23058249
[TBL] [Abstract][Full Text] [Related]
2. Prognostic significance of molecular markers and extent of resection in primary glioblastoma patients.
Felsberg J; Rapp M; Loeser S; Fimmers R; Stummer W; Goeppert M; Steiger HJ; Friedensdorf B; Reifenberger G; Sabel MC
Clin Cancer Res; 2009 Nov; 15(21):6683-93. PubMed ID: 19861461
[TBL] [Abstract][Full Text] [Related]
3. Molecular predictors of progression-free and overall survival in patients with newly diagnosed glioblastoma: a prospective translational study of the German Glioma Network.
Weller M; Felsberg J; Hartmann C; Berger H; Steinbach JP; Schramm J; Westphal M; Schackert G; Simon M; Tonn JC; Heese O; Krex D; Nikkhah G; Pietsch T; Wiestler O; Reifenberger G; von Deimling A; Loeffler M
J Clin Oncol; 2009 Dec; 27(34):5743-50. PubMed ID: 19805672
[TBL] [Abstract][Full Text] [Related]
4. Genetic analyses for predictors of radiation response in glioblastoma.
Shih HA; Betensky RA; Dorfman MV; Louis DN; Loeffler JS; Batchelor TT
Int J Radiat Oncol Biol Phys; 2005 Nov; 63(3):704-10. PubMed ID: 15978739
[TBL] [Abstract][Full Text] [Related]
5. Loss of heterozygosity analysis in malignant gliomas.
Mizoguchi M; Kuga D; Guan Y; Hata N; Nakamizo A; Yoshimoto K; Sasaki T
Brain Tumor Pathol; 2011 Jul; 28(3):191-6. PubMed ID: 21629980
[TBL] [Abstract][Full Text] [Related]
6. Correlation of histology and molecular genetic analysis of 1p, 19q, 10q, TP53, EGFR, CDK4, and CDKN2A in 91 astrocytic and oligodendroglial tumors.
Ueki K; Nishikawa R; Nakazato Y; Hirose T; Hirato J; Funada N; Fujimaki T; Hojo S; Kubo O; Ide T; Usui M; Ochiai C; Ito S; Takahashi H; Mukasa A; Asai A; Kirino T
Clin Cancer Res; 2002 Jan; 8(1):196-201. PubMed ID: 11801559
[TBL] [Abstract][Full Text] [Related]
7. Immunohistochemical and molecular genetics study of a granular cell astrocytoma: a case report of malignant transformation to a glioblastoma.
Ishii T; Mizukawa K; Sasayama T; Sasaki H; Hayashi S; Nakamizo S; Tanaka H; Tanaka K; Hara S; Hirai C; Itoh T; Kohmura E
Neuropathology; 2013 Jun; 33(3):299-305. PubMed ID: 22994265
[TBL] [Abstract][Full Text] [Related]
8. Genetic alterations associated with glioma progression.
Kleihues P; Lübbe J; Watanabe K; von Ammon K; Ohgaki H
Verh Dtsch Ges Pathol; 1994; 78():43-7. PubMed ID: 7534015
[TBL] [Abstract][Full Text] [Related]
9. A new der(1;7)(q10;p10) leading to a singular 1p loss in a case of glioblastoma with oligodendroglioma component.
Gadji M; Crous-Tsanaclis AM; Mathieu D; Mai S; Fortin D; Drouin R
Neuropathology; 2014 Apr; 34(2):170-8. PubMed ID: 24118308
[TBL] [Abstract][Full Text] [Related]
10. Applicable advances in the molecular pathology of glioblastoma.
Ranjit M; Motomura K; Ohka F; Wakabayashi T; Natsume A
Brain Tumor Pathol; 2015 Jul; 32(3):153-62. PubMed ID: 26078107
[TBL] [Abstract][Full Text] [Related]
11. [Malignant gliomas. Oncogenic considerations].
Pérez-Ortiz L; Zaldívar-Vaillant T; Tamayo-Suárez JD
Rev Neurol; 2000 Jul 1-15; 31(1):49-52. PubMed ID: 10948584
[TBL] [Abstract][Full Text] [Related]
12. Evidence-Based Diagnostic Algorithm for Glioma: Analysis of the Results of Pathology Panel Review and Molecular Parameters of EORTC 26951 and 26882 Trials.
Kros JM; Huizer K; Hernández-Laín A; Marucci G; Michotte A; Pollo B; Rushing EJ; Ribalta T; French P; Jaminé D; Bekka N; Lacombe D; van den Bent MJ; Gorlia T
J Clin Oncol; 2015 Jun; 33(17):1943-50. PubMed ID: 25918297
[TBL] [Abstract][Full Text] [Related]
13. Lipidized glioblastoma: pathological and molecular characteristics.
Singh AD; Iftinca M; Easaw JC
Neuropathology; 2013 Feb; 33(1):87-92. PubMed ID: 22640269
[TBL] [Abstract][Full Text] [Related]
14. Chromosome 1p/19q status combined with expression of p53 protein improves the diagnostic and prognostic evaluation of oligodendrogliomas.
Xiong J; Liu Y; Wang Y; Ke RH; Mao Y; Ye ZR
Chin Med J (Engl); 2010 Dec; 123(24):3566-73. PubMed ID: 22166632
[TBL] [Abstract][Full Text] [Related]
15. Molecular and clinical analysis of glioblastoma with an oligodendroglial component (GBMO).
Nakamura H; Makino K; Kuratsu J
Brain Tumor Pathol; 2011 Jul; 28(3):185-90. PubMed ID: 21629979
[TBL] [Abstract][Full Text] [Related]
16. Identification of oligodendroglioma specific chromosomal copy number changes in the glioblastoma MI-4 cell line by array-CGH and FISH analyses.
Magnani I; Moroni RF; Roversi G; Beghini A; Pfundt R; Schoenmakers EF; Larizza L
Cancer Genet Cytogenet; 2005 Sep; 161(2):140-5. PubMed ID: 16102584
[TBL] [Abstract][Full Text] [Related]
17. Molecular pathogenesis of pediatric astrocytic tumors.
Nakamura M; Shimada K; Ishida E; Higuchi T; Nakase H; Sakaki T; Konishi N
Neuro Oncol; 2007 Apr; 9(2):113-23. PubMed ID: 17327574
[TBL] [Abstract][Full Text] [Related]
18. Prognostic stratification of patients with anaplastic gliomas according to genetic profile.
Dehais C; Laigle-Donadey F; Marie Y; Kujas M; Lejeune J; Benouaich-Amiel A; Pedretti M; Polivka M; Xuan KH; Thillet J; Delattre JY; Sanson M
Cancer; 2006 Oct; 107(8):1891-7. PubMed ID: 16986124
[TBL] [Abstract][Full Text] [Related]
19. Longitudinal assessment of genetic and epigenetic markers in oligodendrogliomas.
Lavon I; Zrihan D; Zelikovitch B; Fellig Y; Fuchs D; Soffer D; Siegal T
Clin Cancer Res; 2007 Mar; 13(5):1429-37. PubMed ID: 17332285
[TBL] [Abstract][Full Text] [Related]
20. A practical review of prognostic correlations of molecular biomarkers in glioblastoma.
Karsy M; Neil JA; Guan J; Mahan MA; Colman H; Jensen RL
Neurosurg Focus; 2015 Mar; 38(3):E4. PubMed ID: 25727226
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]